PTC Therapeutics (PTCT) Insider Trading & Ownership

$25.21
-0.20 (-0.79%)
(As of 04/24/2024 ET)

PTC Therapeutics (NASDAQ:PTCT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.30%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$198,737.00
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$2.67 M
Get PTCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling PTC Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PTCT Insider Buying and Selling by Quarter

PTC Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/19/2024Matthew B KleinCEOSell3,361$24.89$83,655.29  
4/17/2024Eric PauwelsCEOSell787$25.14$19,785.18  
4/2/2024Lee Scott GoldenEVPSell526$28.37$14,922.62  
1/30/2024Christine Marie UtterCAOSell318$27.25$8,665.50  
1/30/2024Mark Elliott BouldingVPSell794$27.25$21,636.50  
1/30/2024Neil Gregory AlmsteadInsiderSell618$27.25$16,840.50  
1/22/2024Allan Steven JacobsonDirectorSell10,000$27.38$273,800.00  
1/8/2024Christine Marie UtterCAOSell1,188$28.64$34,024.32  
1/8/2024Eric PauwelsInsiderSell1,569$28.64$44,936.16  
1/8/2024Mark Elliott BouldingVPSell1,457$28.64$41,728.48  
1/8/2024Matthew B KleinCEOSell2,237$28.64$64,067.68  
1/8/2024Michael SchmertzlerDirectorSell1,500$27.81$41,715.00  
1/5/2024Matthew B KleinCEOSell10,107$27.15$274,405.05  
12/12/2023Pierre GravierCFOBuy7,700$25.81$198,737.00  
9/6/2023Alethia YoungDirectorSell11,666$39.86$465,006.76  
5/11/2023Allan Steven JacobsonDirectorSell23,000$55.08$1,266,840.00  
(Data available from 1/1/2013 forward)

PTCT Insider Trading Activity - Frequently Asked Questions

Who is on PTC Therapeutics's Insider Roster?

The list of insiders at PTC Therapeutics includes Alethia Young, Allan Steven Jacobson, Christine Marie Utter, David P Southwell, Dawn Svoronos, Emily Luisa Hill, Emma Reeve, Eric Pauwels, Lee Scott Golden, Mark Elliott Boulding, Matthew B Klein, Michael Schmertzler, Neil Gregory Almstead, Pierre Gravier, Stephanie Okey, and Stuart Walter Peltz. Learn more on insiders at PTCT.

What percentage of PTC Therapeutics stock is owned by insiders?

5.30% of PTC Therapeutics stock is owned by insiders. Learn more on PTCT's insider holdings.

Which PTC Therapeutics insiders have been buying company stock?

The following insider purchased PTCT shares in the last 24 months: Pierre Gravier ($198,737.00).

How much insider buying is happening at PTC Therapeutics?

Insiders have purchased a total of 7,700 PTCT shares in the last 24 months for a total of $198,737.00 bought.

Which PTC Therapeutics insiders have been selling company stock?

The following insiders have sold PTCT shares in the last 24 months: Alethia Young ($465,006.76), Allan Steven Jacobson ($1,540,640.00), Christine Marie Utter ($1,789,819.91), David P Southwell ($1,162,900.42), Emily Luisa Hill ($418,274.36), Emma Reeve ($238,256.40), Eric Pauwels ($136,960.42), Lee Scott Golden ($14,922.62), Mark Elliott Boulding ($3,422,384.44), Matthew B Klein ($615,145.76), Michael Schmertzler ($41,715.00), Neil Gregory Almstead ($63,658.94), Stephanie Okey ($118,519.52), and Stuart Walter Peltz ($257,406.01).

How much insider selling is happening at PTC Therapeutics?

Insiders have sold a total of 224,852 PTC Therapeutics shares in the last 24 months for a total of $10,285,610.56 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:PTCT) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners